Last reviewed · How we verify
General Anesthesia (GA) — Competitive Intelligence Brief
marketed
General anesthetic (combination therapy)
Anesthesiology
Small molecule
Live · refreshed every 30 min
Target snapshot
General Anesthesia (GA) (General Anesthesia (GA)) — The University of Texas Health Science Center, Houston. General anesthesia depresses the central nervous system through multiple molecular pathways to produce unconsciousness, analgesia, and muscle relaxation.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| General Anesthesia (GA) TARGET | General Anesthesia (GA) | The University of Texas Health Science Center, Houston | marketed | General anesthetic (combination therapy) |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (General anesthetic (combination therapy) class)
- The University of Texas Health Science Center, Houston · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- General Anesthesia (GA) CI watch — RSS
- General Anesthesia (GA) CI watch — Atom
- General Anesthesia (GA) CI watch — JSON
- General Anesthesia (GA) alone — RSS
- Whole General anesthetic (combination therapy) class — RSS
Cite this brief
Drug Landscape (2026). General Anesthesia (GA) — Competitive Intelligence Brief. https://druglandscape.com/ci/general-anesthesia-ga. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab